<PAGE>
----------------------------------
OMB APPROVAL
----------------------------------
OMB Number: 3235-0145
Expires: December 31, 1997
Estimated average burden
hours per response........14.90
----------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
________________FemRx, Inc.___________________
(Name of Issuer)
_______Common Stock, $0.001 par value___________
(Title of Class of Securities)
____________ 314463 10 0 __________________
(CUSIP Number)
Check the following box if a fee is being paid with this statement / /.
(A fee is not required only if the filing person: (1) has a previous statement
on file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 6 pages
<PAGE>
--------------------- ------------------
CUSIP No. 314463 10 0 13G Page 2 of 6 Pages
--------------------- ------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Dr. Arnold J. Kresch
2 CHECK THE APPROPRIATE BOX IF A MEMBEROF A GROUP* (a) / /
(b) / /
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
California, United States
NUMBER OF 5 SOLE VOTING POWER
SHARES 461,301
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
6 SHARED VOTING POWER
-0-
7 SOLE DISPOSITIVE POWER
461,301
8 SHARED DISPOSITIVE POWER
-0-
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
461,3011
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.2%
12 TYPE OF REPORTING PERSON*
IN
1 Includes 451,626 shares held by Kresch Medical Research, LLC.
*SEE INSTRUCTION BEFORE FILLING OUT!
Page 2 of 6 pages
<PAGE>
--------------------- -----------------
CUSIP No. 314463 10 0 13G Page 3 of 6 Pages
--------------------- -----------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Kresch Medical Research, LLC
2 CHECK THE APPROPRIATE BOX IF A MEMBEROF A GROUP* (a) / /
(b) / /
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
California, United States
NUMBER OF 5 SOLE VOTING POWER
SHARES 451,926
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
6 SHARED VOTING POWER
-0-
7 SOLE DISPOSITIVE POWER
451,926
8 SHARED DISPOSITIVE POWER
-0-
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
451,926
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.1%
12 TYPE OF REPORTING PERSON*
OO
*SEE INSTRUCTION BEFORE FILLING OUT!
Page 3 of 6 pages
<PAGE>
Item .
(a) Name of Issuer: FemRx, Inc.
(b) Address of Issuer's Principal Executive Offices:
1221 Innsbruck Drive
Sunnyvale, CA 94089
Item .
(a) Name of Person Filing:
Dr. Arnold J. Kresch
Kresch Medical Reseach, LLC ("KMR")
(b) Address of Principal Business Office or, if none, Residence:
780 Welch Road, Suite 206
Palo Alto, CA 94304-1518
(c) Citizenship:
Dr. Arnold J. Kresch: California, United States
KMR: California, United States
(d) Title of Class of Securities: Common Stock, $0.001 par value
(e) CUSIP Number: 314463 10 0
Item If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b),
check whether the person filing is a:
Not applicable.
Item Ownership
(a) Amount Beneficially Owned:
Dr. Arnold J. Kresch: 461,301*
KMR: 451,926
* Includes 451,626 shares held by Kresch Medical
Research, LLC.
(b) Percent of Class:
Dr. Arnold J. Kresch: 5.2%
KMR: 5.1%
Page 4 of 6 pages
<PAGE>
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
Dr. Arnold J. Kresch: 461,301
KMR: 451,926
(ii) shared power to vote or to direct the vote:
Dr. Arnold J. Kresch: 0
KMR: 0
(iii) sole power to dispose or to direct the disposition of:
Dr. Arnold J. Kresch: 461,301
KMR: 451,926
(iv) shared power to dispose or to direct the disposition of:
Dr. Arnold J. Kresch: 0
KMR: 0
Item Ownership of Five Percent or Less of a Class
Not applicable.
Item Ownership of More than Five Percent on Behalf of Another Person
Not applicable.
Item Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding Company
Not applicable.
Item Identification and Classification of Members of the Group
Not applicable.
Item Notice of Dissolution of a Group
Not applicable.
Item Certification
Not applicable.
Page 5 of 6 pages
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 12, 1998
Date
/s/ Arnold J. Kresch
--------------------
Dr. Arnold J. Kresch
Kresch Medical Research, LLC
/s/ Arnold J. Kresch
--------------------
Dr. Arnold J. Kresch, Owner
Page 6 of 6 pages
